{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:22:33Z","timestamp":1790515353311,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T00:00:00Z","timestamp":1625443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T00:00:00Z","timestamp":1625443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Grants from Japan Agency for Medical Research and Development","award":["JP18ck0106198h0003"],"award-info":[{"award-number":["JP18ck0106198h0003"]}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["JP18K09715"],"award-info":[{"award-number":["JP18K09715"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["JP18H02891"],"award-info":[{"award-number":["JP18H02891"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["JP18H05092"],"award-info":[{"award-number":["JP18H05092"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19ck0106406h0002"],"award-info":[{"award-number":["JP19ck0106406h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Tumor endothelial cells (TECs) reportedly exhibit altered phenotypes. We have demonstrated that TECs acquire drug resistance with the upregulation of P-glycoprotein (P-gp, ABCB1), contrary to traditional assumptions. Furthermore, P-gp expression was higher in TECs of highly metastatic tumors than in those of low metastatic tumors. However, the detailed mechanism of differential P-gp expression in TECs remains unclear. miRNA was identified in highly metastatic tumor extracellular vesicles (EVs) and the roles of miRNA in endothelial cell resistance were analyzed in vitro and in vivo. In the present study, we found that treatment of highly metastatic tumor-conditioned medium induced resistance to 5-fluorouracil (5-FU) with interleukin-6 (IL-6) upregulation in endothelial cells (ECs). Among the soluble factors secreted from highly metastatic tumors, we focused on EVs and determined that miR-1246 was contained at a higher level in highly metastatic tumor EVs than in low metastatic tumor EVs. Furthermore, miR-1246 was transported via the EVs into ECs and induced IL-6 expression. Upregulated IL-6 induced resistance to 5-FU with STAT3 and Akt activation in ECs in an autocrine manner. These results suggested that highly metastatic tumors induce drug resistance in ECs by transporting miR-1246 through EVs.<\/jats:p>","DOI":"10.1038\/s41598-021-92879-5","type":"journal-article","created":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T06:04:04Z","timestamp":1625465044000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["miRNA-1246 in extracellular vesicles secreted from metastatic tumor induces drug resistance in tumor endothelial cells"],"prefix":"10.1038","volume":"11","author":[{"given":"Chisaho","family":"Torii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nako","family":"Maishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisuke","family":"Kawamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Minami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Tsumita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Towfik","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Ochiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Hida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Hida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,5]]},"reference":[{"key":"92879_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/nm0195-27","volume":"1","author":"J Folkman","year":"1995","unstructured":"Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1, 27\u201331 (1995).","journal-title":"Nat. Med."},{"key":"92879_CR2","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrd2115","volume":"6","author":"J Folkman","year":"2007","unstructured":"Folkman, J. Angiogenesis: An organizing principle for drug discovery? Nat. Rev. Drug Discov. 6, 273\u2013286 (2007).","journal-title":"Nat. Rev. Drug Discov."},{"key":"92879_CR3","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1200\/JCO.2004.11.022","volume":"22","author":"DH Johnson","year":"2004","unstructured":"Johnson, D. H. et al. Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer. J. Clin. Oncol. 22, 2184\u20132191 (2004).","journal-title":"J. Clin. Oncol."},{"key":"92879_CR4","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1111\/j.1349-7006.2007.00620.x","volume":"98","author":"VL Keedy","year":"2007","unstructured":"Keedy, V. L. & Sandler, A. B. Inhibition of angiogenesis in the treatment of non-small cell lung cancer. Cancer Sci. 98, 1825\u20131830 (2007).","journal-title":"Cancer Sci."},{"key":"92879_CR5","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ccr.2009.01.027","volume":"15","author":"M Paez-Ribes","year":"2009","unstructured":"Paez-Ribes, M. et al. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 15, 220\u2013231 (2009).","journal-title":"Cancer Cell"},{"key":"92879_CR6","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ccr.2009.01.021","volume":"15","author":"JML Ebos","year":"2009","unstructured":"Ebos, J. M. L. et al. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 15, 232\u2013239 (2009).","journal-title":"Cancer Cell"},{"key":"92879_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/ncponc0403","volume":"3","author":"RK Jain","year":"2006","unstructured":"Jain, R. K., Duda, D. G., Clark, J. W. & Loeffler, J. S. Lessons from phase III clinical trials on anti-VEGF therapy for cancer. Nat. Clin. Pract. Oncol. 3, 24\u201340 (2006).","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"92879_CR8","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1158\/1078-0432.CCR-06-1989","volume":"13","author":"BI Rini","year":"2007","unstructured":"Rini, B. I. Vascular endothelial growth factor-targeted therapy in renal cell carcinoma: Current status and future directions. Clin. Cancer Res. 13, 1098\u20131106 (2007).","journal-title":"Clin. Cancer Res."},{"key":"92879_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1023\/A:1026574416001","volume":"19","author":"R Auerbach","year":"2000","unstructured":"Auerbach, R., Akhtar, N., Lewis, R. L. & Shinners, B. L. Angiogenesis assays: Problems and pitfalls. Cancer Metast. Rev. 19, 167\u2013172 (2000).","journal-title":"Cancer Metast. Rev."},{"key":"92879_CR10","first-page":"45S","volume":"19","author":"RS Kerbel","year":"2001","unstructured":"Kerbel, R. S. Clinical trials of antiangiogenic drugs: Opportunities, problems, and assessment of initial results. J. Clin. Oncol. 19, 45S-51S (2001).","journal-title":"J. Clin. Oncol."},{"key":"92879_CR11","doi-asserted-by":"publisher","first-page":"7002","DOI":"10.1021\/acs.jafc.6b02509","volume":"64","author":"G Zhang","year":"2016","unstructured":"Zhang, G. et al. Repression of human hepatocellular carcinoma growth by regulating Met\/EGFR\/VEGFR-Akt\/NF-\u03baB pathways with theanine and its derivative, (R)-2-(6,8-Dibromo-2-oxo-2H-chromene-3-carboxamido)-5-(ethylamino)-5-oxopentanoic ethyl ester (DTBrC). J. Agric. Food Chem. 64, 7002\u20137013 (2016).","journal-title":"J. Agric. Food Chem."},{"key":"92879_CR12","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1056\/NEJMoa033153","volume":"351","author":"B Streubel","year":"2004","unstructured":"Streubel, B. et al. Lymphoma-specific genetic aberrations in microvascular endothelial cells in B-cell lymphomas. N. Engl. J. Med. 351, 250\u2013259 (2004).","journal-title":"N. Engl. J. Med."},{"key":"92879_CR13","doi-asserted-by":"publisher","first-page":"8249","DOI":"10.1158\/0008-5472.CAN-04-1567","volume":"64","author":"K Hida","year":"2004","unstructured":"Hida, K. et al. Tumor-associated endothelial cells with cytogenetic abnormalities. Cancer Res. 64, 8249\u20138255 (2004).","journal-title":"Cancer Res."},{"key":"92879_CR14","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.2353\/ajpath.2009.090202","volume":"175","author":"T Akino","year":"2009","unstructured":"Akino, T. et al. Cytogenetic abnormalities of tumor-associated endothelial cells in human malignant tumors. Am. J. Pathol. 175, 2657\u20132667 (2009).","journal-title":"Am. J. Pathol."},{"key":"92879_CR15","doi-asserted-by":"publisher","DOI":"10.1096\/fj.02-0557fje,1-3","author":"B Bussolati","year":"2003","unstructured":"Bussolati, B., Deambrosis, I., Russo, S., Deregibus, M. C. & Camussi, G. Altered angiogenesis and survival in human tumor-derived endothelial cells. FASEB J. https:\/\/doi.org\/10.1096\/fj.02-0557fje,1-3 (2003).","journal-title":"FASEB J."},{"key":"92879_CR16","doi-asserted-by":"publisher","first-page":"4838","DOI":"10.1158\/1078-0432.CCR-08-2780","volume":"15","author":"YQ Xiong","year":"2009","unstructured":"Xiong, Y. Q. et al. Human hepatocellular carcinoma tumor-derived endothelial cells manifest increased angiogenesis capability and drug resistance compared with normal endothelial cells. Clin. Cancer Res. 15, 4838\u20134846 (2009).","journal-title":"Clin. Cancer Res."},{"key":"92879_CR17","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1111\/cas.13388","volume":"108","author":"K Hida","year":"2017","unstructured":"Hida, K. et al. Tumor endothelial cells with high aldehyde dehydrogenase activity show drug resistance. Cancer Sci. 108, 2195\u20132203 (2017).","journal-title":"Cancer Sci."},{"key":"92879_CR18","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.ajpath.2011.11.029","volume":"180","author":"K Akiyama","year":"2012","unstructured":"Akiyama, K. et al. Tumor endothelial cells acquire drug resistance by MDR1 up-regulation via VEGF signaling in tumor microenvironment. Am. J. Pathol. 180, 1283\u20131293 (2012).","journal-title":"Am. J. Pathol."},{"key":"92879_CR19","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-3791","author":"H Kikuchi","year":"2020","unstructured":"Kikuchi, H. et al. Chemotherapy-induced IL-8 upregulates MDR1\/ABCB1 in tumor blood vessels and results in unfavorable outcome. Cancer Res. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-3791 (2020).","journal-title":"Cancer Res."},{"key":"92879_CR20","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.ajpath.2011.11.035","volume":"180","author":"N Ohga","year":"2012","unstructured":"Ohga, N. et al. Heterogeneity of tumor endothelial cells. Am. J. Pathol. 180, 1294\u20131307 (2012).","journal-title":"Am. J. Pathol."},{"key":"92879_CR21","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.1158\/0008-5472.CAN-15-2998","volume":"76","author":"H Naito","year":"2016","unstructured":"Naito, H. et al. Endothelial side population cells contribute to tumor angiogenesis and antiangiogenic drug resistance. Can. Res. 76, 3200\u20133210 (2016).","journal-title":"Can. Res."},{"key":"92879_CR22","doi-asserted-by":"publisher","first-page":"842849","DOI":"10.1155\/2011\/842849","volume":"2011","author":"C Yang","year":"2011","unstructured":"Yang, C. & Robbins, P. D. The roles of tumor-derived exosomes in cancer pathogenesis. Clin. Dev. Immunol. 2011, 842849 (2011).","journal-title":"Clin. Dev. Immunol."},{"key":"92879_CR23","doi-asserted-by":"publisher","first-page":"4920","DOI":"10.1158\/0008-5472.CAN-12-0925","volume":"72","author":"A Bobrie","year":"2012","unstructured":"Bobrie, A. et al. Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression. Cancer Res. 72, 4920\u20134930 (2012).","journal-title":"Cancer Res."},{"key":"92879_CR24","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/nm.2753","volume":"18","author":"H Peinado","year":"2012","unstructured":"Peinado, H. et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat. Med. 18, 883\u2013891 (2012).","journal-title":"Nat. Med."},{"key":"92879_CR25","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"H Valadi","year":"2007","unstructured":"Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654\u2013659 (2007).","journal-title":"Nat. Cell Biol."},{"key":"92879_CR26","doi-asserted-by":"publisher","first-page":"e34045","DOI":"10.1371\/journal.pone.0034045","volume":"7","author":"T Kawamoto","year":"2012","unstructured":"Kawamoto, T. et al. Tumor-derived microvesicles induce proangiogenic phenotype in endothelial cells via endocytosis. PLoS ONE 7, e34045\u2013e34049 (2012).","journal-title":"PLoS ONE"},{"key":"92879_CR27","doi-asserted-by":"publisher","first-page":"6716","DOI":"10.1038\/ncomms7716","volume":"6","author":"N Tominaga","year":"2015","unstructured":"Tominaga, N. et al. Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier. Nat. Commun. 6, 6716 (2015).","journal-title":"Nat. Commun."},{"key":"92879_CR28","doi-asserted-by":"publisher","first-page":"4929","DOI":"10.1038\/onc.2017.105","volume":"36","author":"YL Hsu","year":"2017","unstructured":"Hsu, Y. L. et al. Hypoxic lung cancer-secreted exosomal miR-23a increased angiogenesis and vascular permeability by targeting prolyl hydroxylase and tight junction protein ZO-1. Oncogene 36, 4929\u20134942 (2017).","journal-title":"Oncogene"},{"key":"92879_CR29","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel, D. P. MicroRNAs: Target recognition and regulatory functions. Cell 136, 215\u2013233 (2009).","journal-title":"Cell"},{"key":"92879_CR30","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/med.20215","volume":"32","author":"K Zen","year":"2012","unstructured":"Zen, K. & Zhang, C. Y. Circulating microRNAs: A novel class of biomarkers to diagnose and monitor human cancers. Med. Res. Rev. 32, 326\u2013348 (2012).","journal-title":"Med. Res. Rev."},{"key":"92879_CR31","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.pharmthera.2012.08.003","volume":"136","author":"RS Redis","year":"2012","unstructured":"Redis, R. S., Calin, S., Yang, Y., You, M. J. & Calin, G. A. Cell-to-cell miRNA transfer: From body homeostasis to therapy. Pharmacol. Ther. 136, 169\u2013174 (2012).","journal-title":"Pharmacol. Ther."},{"key":"92879_CR32","first-page":"913","volume":"72","author":"JM Kozlowski","year":"1984","unstructured":"Kozlowski, J. M., Hart, I. R., Fidler, I. J. & Hanna, N. A human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice. J. Natl. Cancer Inst. 72, 913\u2013917 (1984).","journal-title":"J. Natl. Cancer Inst."},{"key":"92879_CR33","doi-asserted-by":"publisher","first-page":"29044","DOI":"10.1074\/jbc.M114.555235","volume":"289","author":"J Suehiro","year":"2014","unstructured":"Suehiro, J. et al. Genome-wide approaches reveal functional vascular endothelial growth factor (VEGF)-inducible nuclear factor of activated T cells (NFAT) c1 binding to angiogenesis-related genes in the endothelium. J. Biol. Chem. 289, 29044\u201329059 (2014).","journal-title":"J. Biol. Chem."},{"key":"92879_CR34","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nmeth.4185","volume":"14","author":"Enabling Technologies Consortium","year":"2017","unstructured":"Enabling Technologies Consortium et al. EV-TRACK: Transparent reporting and centralizing knowledge in extracellular vesicle research. Nat. Methods 14, 228\u2013232 (2017).","journal-title":"Nat. Methods"},{"key":"92879_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpb.2015.10.017","volume":"98","author":"T Yamashita","year":"2016","unstructured":"Yamashita, T., Takahashi, Y., Nishikawa, M. & Takakura, Y. Effect of exosome isolation methods on physicochemical properties of exosomes and clearance of exosomes from the blood circulation. Eur. J. Pharm. Biopharm. 98, 1\u20138 (2016).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"92879_CR36","first-page":"8851","volume":"61","author":"D Conze","year":"2001","unstructured":"Conze, D. et al. Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells. Cancer Res. 61, 8851\u20138858 (2001).","journal-title":"Cancer Res."},{"key":"92879_CR37","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.canlet.2010.02.019","volume":"295","author":"Y Wang","year":"2010","unstructured":"Wang, Y. et al. Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells. Cancer Lett. 295, 110\u2013123 (2010).","journal-title":"Cancer Lett."},{"key":"92879_CR38","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nrd3978","volume":"12","author":"SEL Andaloussi","year":"2013","unstructured":"Andaloussi, S. E. L., Mager, I., Breakefield, X. O. & Wood, M. J. Extracellular vesicles: Biology and emerging therapeutic opportunities. Nat. Rev. Drug Discov. 12, 347\u2013357 (2013).","journal-title":"Nat. Rev. Drug Discov."},{"key":"92879_CR39","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1158\/0008-5472.CAN-12-2353","volume":"73","author":"T Ara","year":"2013","unstructured":"Ara, T. et al. Critical role of STAT3 in IL-6-mediated drug resistance in human neuroblastoma. Can. Res. 73, 3852\u20133864 (2013).","journal-title":"Can. Res."},{"key":"92879_CR40","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ccr.2005.09.005","volume":"8","author":"O Casanovas","year":"2005","unstructured":"Casanovas, O., Hicklin, D. J., Bergers, G. & Hanahan, D. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell 8, 299\u2013309 (2005).","journal-title":"Cancer Cell"},{"key":"92879_CR41","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.ajpath.2014.10.017","volume":"185","author":"K Akiyama","year":"2015","unstructured":"Akiyama, K. et al. Inhibition of multidrug transporter in tumor endothelial cells enhances antiangiogenic effects of low-dose metronomic paclitaxel. Am. J. Pathol. 185, 572\u2013580 (2015).","journal-title":"Am. J. Pathol."},{"key":"92879_CR42","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cell.2010.09.043","volume":"143","author":"LA Gilbert","year":"2010","unstructured":"Gilbert, L. A. & Hemann, M. T. DNA damage-mediated induction of a chemoresistant niche. Cell 143, 355\u2013366 (2010).","journal-title":"Cell"},{"key":"92879_CR43","doi-asserted-by":"publisher","first-page":"e113910","DOI":"10.1371\/journal.pone.0113910","volume":"9","author":"H Ohmura-Kakutani","year":"2014","unstructured":"Ohmura-Kakutani, H. et al. Identification of tumor endothelial cells with high aldehyde dehydrogenase activity and a highly angiogenic phenotype. PLoS ONE 9, e113910\u2013e113917 (2014).","journal-title":"PLoS ONE"},{"key":"92879_CR44","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1186\/1471-2407-12-421","volume":"12","author":"HW King","year":"2012","unstructured":"King, H. W., Michael, M. Z. & Gleadle, J. M. Hypoxic enhancement of exosome release by breast cancer cells. BMC Cancer 12, 421 (2012).","journal-title":"BMC Cancer"},{"key":"92879_CR45","doi-asserted-by":"publisher","first-page":"e0138849","DOI":"10.1371\/journal.pone.0138849","volume":"10","author":"NA Garcia","year":"2015","unstructured":"Garcia, N. A., Ontoria-Oviedo, I., Gonzalez-King, H., Diez-Juan, A. & Sepulveda, P. Glucose starvation in cardiomyocytes enhances exosome secretion and promotes angiogenesis in endothelial cells. PLoS ONE 10, e0138849 (2015).","journal-title":"PLoS ONE"},{"key":"92879_CR46","doi-asserted-by":"publisher","first-page":"7312","DOI":"10.1073\/pnas.1220998110","volume":"110","author":"P Kucharzewska","year":"2013","unstructured":"Kucharzewska, P. et al. Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. Proc. Natl. Acad. Sci. U.S.A. 110, 7312\u20137317 (2013).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"92879_CR47","first-page":"1256","volume":"1839","author":"N Yamada","year":"2014","unstructured":"Yamada, N. et al. Colorectal cancer cell-derived microvesicles containing microRNA-1246 promote angiogenesis by activating Smad 1\/5\/8 signaling elicited by PML down-regulation in endothelial cells. Biochem. Biophys. Acta 1839, 1256\u20131272 (2014).","journal-title":"Biochem. Biophys. Acta"},{"key":"92879_CR48","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/bjc.2013.8","volume":"108","author":"N Takeshita","year":"2013","unstructured":"Takeshita, N. et al. Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma. Br. J. Cancer 108, 644\u2013652 (2013).","journal-title":"Br. J. Cancer"},{"key":"92879_CR49","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s00404-014-3260-2","volume":"290","author":"J Chen","year":"2014","unstructured":"Chen, J. et al. MiR-1246 promotes SiHa cervical cancer cell proliferation, invasion, and migration through suppression of its target gene thrombospondin 2. Arch. Gynecol. Obstet. 290, 725\u2013732 (2014).","journal-title":"Arch. Gynecol. Obstet."},{"key":"92879_CR50","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1038\/bjc.2014.454","volume":"111","author":"S Hasegawa","year":"2014","unstructured":"Hasegawa, S. et al. MicroRNA-1246 expression associated with CCNG2-mediated chemoresistance and stemness in pancreatic cancer. Br. J. Cancer 111, 1572\u20131580 (2014).","journal-title":"Br. J. Cancer"},{"key":"92879_CR51","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1186\/1471-2407-14-616","volume":"14","author":"Z Sun","year":"2014","unstructured":"Sun, Z. et al. MicroRNA-1246 enhances migration and invasion through CADM1 in hepatocellular carcinoma. BMC Cancer 14, 616 (2014).","journal-title":"BMC Cancer"},{"key":"92879_CR52","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13000-015-0366-1","volume":"10","author":"W Huang","year":"2015","unstructured":"Huang, W., Li, H. & Luo, R. The microRNA-1246 promotes metastasis in non-small cell lung cancer by targeting cytoplasmic polyadenylation element-binding protein 4. Diagn. Pathol. 10, 127 (2015).","journal-title":"Diagn. Pathol."},{"key":"92879_CR53","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/cancers9010010","volume":"9","author":"DA Leach","year":"2017","unstructured":"Leach, D. A. & Buchanan, G. Stromal androgen receptor in prostate cancer development and progression. Cancers (Basel) 9, 10 (2017).","journal-title":"Cancers (Basel)"},{"key":"92879_CR54","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/modpathol.2013.145","volume":"27","author":"AA Thike","year":"2014","unstructured":"Thike, A. A. et al. Loss of androgen receptor expression predicts early recurrence in triple-negative and basal-like breast cancer. Mod. Pathol. 27, 352\u2013360 (2014).","journal-title":"Mod. Pathol."},{"key":"92879_CR55","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1158\/0008-5472.CAN-13-0594","volume":"74","author":"A Schroeder","year":"2014","unstructured":"Schroeder, A. et al. Loss of androgen receptor expression promotes a stem-like cell phenotype in prostate cancer through STAT3 signaling. Cancer Res. 74, 1227\u20131237 (2014).","journal-title":"Cancer Res."},{"key":"92879_CR56","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1111\/febs.13285","volume":"282","author":"MS Wake","year":"2015","unstructured":"Wake, M. S. & Watson, C. J. STAT3 the oncogene\u2014Still eluding therapy? FEBS J. 282, 2600\u20132611 (2015).","journal-title":"FEBS J."},{"key":"92879_CR57","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.tips.2015.10.001","volume":"37","author":"C Zhao","year":"2016","unstructured":"Zhao, C. et al. Feedback activation of STAT3 as a cancer drug-resistance mechanism. Trends Pharmacol. Sci. 37, 47\u201361 (2016).","journal-title":"Trends Pharmacol. Sci."},{"key":"92879_CR58","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1158\/1078-0432.CCR-02-1441","volume":"10","author":"S Yamamoto","year":"2004","unstructured":"Yamamoto, S. et al. Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma. Clin. Cancer Res. 10, 2846\u20132850 (2004).","journal-title":"Clin. Cancer Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92879-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92879-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92879-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T03:11:29Z","timestamp":1675480289000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92879-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,5]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["92879"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-92879-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-60198\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-60198\/v2","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,5]]},"assertion":[{"value":"27 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13502"}}